Xiong Y - Search Results

1

Xiong Y. Xiong Y. Biochim Biophys Acta. 1996 Aug 8;1288(1):01-5. doi: 10.1016/0304-419x(96)00012-1. Biochim Biophys Acta. 1996. PMID: 8764842 Review. No abstract available.

2

CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis.

Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L, Xiong Y. Franklin DS, et al. Among authors: xiong y. Genes Dev. 1998 Sep 15;12(18):2899-911. doi: 10.1101/gad.12.18.2899. Genes Dev. 1998. PMID: 9744866 Free PMC article.

3

Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase.

Aprelikova O, Xiong Y, Liu ET. Aprelikova O, et al. Among authors: xiong y. J Biol Chem. 1995 Aug 4;270(31):18195-7. doi: 10.1074/jbc.270.31.18195. J Biol Chem. 1995. PMID: 7629134 Free article.

4

Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity.

Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y. Franklin DS, et al. Among authors: xiong y. Mol Cell Biol. 2000 Aug;20(16):6147-58. doi: 10.1128/MCB.20.16.6147-6158.2000. Mol Cell Biol. 2000. PMID: 10913196 Free PMC article.

5

An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation.

Kovalev GI, Franklin DS, Coffield VM, Xiong Y, Su L. Kovalev GI, et al. Among authors: xiong y. J Immunol. 2001 Sep 15;167(6):3285-92. doi: 10.4049/jimmunol.167.6.3285. J Immunol. 2001. PMID: 11544316 Free PMC article.

6

Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.

Zariwala M, Liu E, Xiong Y. Zariwala M, et al. Among authors: xiong y. Oncogene. 1996 Jan 18;12(2):451-5. Oncogene. 1996. PMID: 8570224

7

Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis.

Phelps DE, Hsiao KM, Li Y, Hu N, Franklin DS, Westphal E, Lee EY, Xiong Y. Phelps DE, et al. Among authors: xiong y. Mol Cell Biol. 1998 Apr;18(4):2334-43. doi: 10.1128/MCB.18.4.2334. Mol Cell Biol. 1998. PMID: 9528803 Free PMC article.

8

Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.

Wu H, Wade M, Krall L, Grisham J, Xiong Y, Van Dyke T. Wu H, et al. Among authors: xiong y. Genes Dev. 1996 Feb 1;10(3):245-60. doi: 10.1101/gad.10.3.245. Genes Dev. 1996. PMID: 8595876 Free article.

9

Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation.

Xiong Y, Kuppuswamy D, Li Y, Livanos EM, Hixon M, White A, Beach D, Tlsty TD. Xiong Y, et al. J Virol. 1996 Feb;70(2):999-1008. doi: 10.1128/JVI.70.2.999-1008.1996. J Virol. 1996. PMID: 8551641 Free PMC article.

10

Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins.

Zariwala M, Liu J, Xiong Y. Zariwala M, et al. Among authors: xiong y. Oncogene. 1998 Nov 26;17(21):2787-98. doi: 10.1038/sj.onc.1202505. Oncogene. 1998. PMID: 9840943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,132 results

Search Page

Filters